Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients

Background: The prevalence of atrial fibrillation (AF) is high in older patients. The present study aimed to estimate the age and sex specific prevalence of clinical and screen-detected atrial fibrillation (AF) in hospitalized patients. Methods: The STAR-FIB cohort study was a prospective cohort stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laurent Roten, Eleni Goulouti, Anna Lam, Elena Elchinova, Nikolas Nozica, Alessandro Spirito, Severin Wittmer, Mattia Branca, Helge Servatius, Fabian Noti, Jens Seiler, Samuel H Baldinger, Andreas Haeberlin, Stefano de Marchi, Babken Asatryan, Nicolas Rodondi, Jacques Donzé, Drahomir Aujesky, Hildegard Tanner, Tobias Reichlin, Peter Jüni
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/d13d828289654bbf87cc80d5da7587c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d13d828289654bbf87cc80d5da7587c6
record_format dspace
spelling oai:doaj.org-article:d13d828289654bbf87cc80d5da7587c62021-11-11T17:31:53ZAge and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients10.3390/jcm102148712077-0383https://doaj.org/article/d13d828289654bbf87cc80d5da7587c62021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/4871https://doaj.org/toc/2077-0383Background: The prevalence of atrial fibrillation (AF) is high in older patients. The present study aimed to estimate the age and sex specific prevalence of clinical and screen-detected atrial fibrillation (AF) in hospitalized patients. Methods: The STAR-FIB cohort study was a prospective cohort study recruiting participants from a large source population of hospitalized patients aged 65–84 years. The estimated size of the source population was 26,035 (95% CI 25,918–26,152), and 795 consenting patients without clinical AF were included in the cohort study after stratification by sex and age (49.2% females; mean age 74.7 years). Patients in the cohort study underwent three seven-day Holter ECGs in intervals of two months to screen for AF. Results: In the source population, the estimated prevalence of clinical AF was 22.2% (95% CI 18.4–26.1), 23.8% for males (95% CI 20.9–26.6) and 19.8% for females (95% CI 17.3–22.4; <i>p</i> for difference between sexes, 0.004). There was a linear trend for an increase in the prevalence of clinical AF with increasing age, overall and in both sexes. In the cohort study, AF was newly diagnosed in 38 patients, for an estimated prevalence of screen-detected AF of 4.9% overall (95% CI 3.3–6.6), 5.5% in males (95% CI 3.2–7.8) and 4.0% in females (95% CI 2.0–6.0; <i>p</i> for difference between sexes, 0.041). The estimated prevalence of screen-detected AF in the source population was 3.8% overall, 4.2% in males and 3.2% in females. Conclusion: In a large hospital-based patient population aged 65–84 years, the prevalence of clinical AF and of screen-detected AF was 22.2% and 3.8%, respectively, and significantly higher in males than females.Laurent RotenEleni GouloutiAnna LamElena ElchinovaNikolas NozicaAlessandro SpiritoSeverin WittmerMattia BrancaHelge ServatiusFabian NotiJens SeilerSamuel H BaldingerAndreas HaeberlinStefano de MarchiBabken AsatryanNicolas RodondiJacques DonzéDrahomir AujeskyHildegard TannerTobias ReichlinPeter JüniMDPI AGarticleatrial fibrillationscreeningparoxysmalsubclinicalsilentHolter ECGMedicineRENJournal of Clinical Medicine, Vol 10, Iss 4871, p 4871 (2021)
institution DOAJ
collection DOAJ
language EN
topic atrial fibrillation
screening
paroxysmal
subclinical
silent
Holter ECG
Medicine
R
spellingShingle atrial fibrillation
screening
paroxysmal
subclinical
silent
Holter ECG
Medicine
R
Laurent Roten
Eleni Goulouti
Anna Lam
Elena Elchinova
Nikolas Nozica
Alessandro Spirito
Severin Wittmer
Mattia Branca
Helge Servatius
Fabian Noti
Jens Seiler
Samuel H Baldinger
Andreas Haeberlin
Stefano de Marchi
Babken Asatryan
Nicolas Rodondi
Jacques Donzé
Drahomir Aujesky
Hildegard Tanner
Tobias Reichlin
Peter Jüni
Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients
description Background: The prevalence of atrial fibrillation (AF) is high in older patients. The present study aimed to estimate the age and sex specific prevalence of clinical and screen-detected atrial fibrillation (AF) in hospitalized patients. Methods: The STAR-FIB cohort study was a prospective cohort study recruiting participants from a large source population of hospitalized patients aged 65–84 years. The estimated size of the source population was 26,035 (95% CI 25,918–26,152), and 795 consenting patients without clinical AF were included in the cohort study after stratification by sex and age (49.2% females; mean age 74.7 years). Patients in the cohort study underwent three seven-day Holter ECGs in intervals of two months to screen for AF. Results: In the source population, the estimated prevalence of clinical AF was 22.2% (95% CI 18.4–26.1), 23.8% for males (95% CI 20.9–26.6) and 19.8% for females (95% CI 17.3–22.4; <i>p</i> for difference between sexes, 0.004). There was a linear trend for an increase in the prevalence of clinical AF with increasing age, overall and in both sexes. In the cohort study, AF was newly diagnosed in 38 patients, for an estimated prevalence of screen-detected AF of 4.9% overall (95% CI 3.3–6.6), 5.5% in males (95% CI 3.2–7.8) and 4.0% in females (95% CI 2.0–6.0; <i>p</i> for difference between sexes, 0.041). The estimated prevalence of screen-detected AF in the source population was 3.8% overall, 4.2% in males and 3.2% in females. Conclusion: In a large hospital-based patient population aged 65–84 years, the prevalence of clinical AF and of screen-detected AF was 22.2% and 3.8%, respectively, and significantly higher in males than females.
format article
author Laurent Roten
Eleni Goulouti
Anna Lam
Elena Elchinova
Nikolas Nozica
Alessandro Spirito
Severin Wittmer
Mattia Branca
Helge Servatius
Fabian Noti
Jens Seiler
Samuel H Baldinger
Andreas Haeberlin
Stefano de Marchi
Babken Asatryan
Nicolas Rodondi
Jacques Donzé
Drahomir Aujesky
Hildegard Tanner
Tobias Reichlin
Peter Jüni
author_facet Laurent Roten
Eleni Goulouti
Anna Lam
Elena Elchinova
Nikolas Nozica
Alessandro Spirito
Severin Wittmer
Mattia Branca
Helge Servatius
Fabian Noti
Jens Seiler
Samuel H Baldinger
Andreas Haeberlin
Stefano de Marchi
Babken Asatryan
Nicolas Rodondi
Jacques Donzé
Drahomir Aujesky
Hildegard Tanner
Tobias Reichlin
Peter Jüni
author_sort Laurent Roten
title Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients
title_short Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients
title_full Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients
title_fullStr Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients
title_full_unstemmed Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients
title_sort age and sex specific prevalence of clinical and screen-detected atrial fibrillation in hospitalized patients
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d13d828289654bbf87cc80d5da7587c6
work_keys_str_mv AT laurentroten ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT elenigoulouti ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT annalam ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT elenaelchinova ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT nikolasnozica ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT alessandrospirito ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT severinwittmer ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT mattiabranca ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT helgeservatius ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT fabiannoti ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT jensseiler ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT samuelhbaldinger ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT andreashaeberlin ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT stefanodemarchi ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT babkenasatryan ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT nicolasrodondi ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT jacquesdonze ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT drahomiraujesky ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT hildegardtanner ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT tobiasreichlin ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
AT peterjuni ageandsexspecificprevalenceofclinicalandscreendetectedatrialfibrillationinhospitalizedpatients
_version_ 1718432089709215744